NASDAQ · DENTAL EQUIPMENT & SUPPLIES · LARGE CAP
Dentsply Sirona Inc. XRAY
19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$3.7B
▼ 3.0% vs FY2024
EPS · FY25
$-3.00
Dividend / sh · FY25
$0.64
Payout · FY25
-21%
ROE · FY25
-36.5%
Net margin · FY25
-16.2%
Dividend coverage
-4.7×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.7B
Revenue, FY2025 · full 19-year series below
Revenue
Net income
The company lost 16 cents on every revenue dollar this year.
Per share
USD -3.00
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-36.5%
Return on equity, FY2025
ROE
Operating margin-11.5%
Net margin-16.2%
Return on assets-10.7%
Each USD of equity lost 36 cents this year.
Returned to shareholders
USD 128.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 128.0M
Net buybacksUSD 0.00
Share of profit-21.4%
Consecutive raises—
USD 128.0M in dividends went back to shareholders in a year without profit.
Growth
+2.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−2.1%
+2.0%
+3.2%
+3.4%
Dividend / share
+8.6%
+9.9%
Returned to shareholders
−19.8%
−10.0%
+0.9%
−3.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.20B
Shares outstanding, FY2025
Change, 5 years−8.7%
Change, 10 years—
The share count shrank 9% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 5.4B
total assets, end of FY2025
Total assetsUSD 5.4B
EquityUSD 1.3B
CashUSD 326.0M
Gross debtUSD 2.2B
Net debtUSD 1.9B
Current ratio1.51×
Net debt stands at 143% of equity.
History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
3.7
3.8
4.0
3.9
4.2
3.3
4.0
4.0
4.0
3.7
2.7
2.9
3.0
2.9
2.5
2.2
2.2
2.2
2.0
Operating income $B
−0.4
−0.9
−0.1
−0.9
0.6
−0.0
0.4
−1.0
−1.6
0.5
0.4
0.4
0.4
0.4
0.3
0.4
0.4
0.4
0.4
EBITDA $B
−0.1
−0.5
0.3
−0.6
1.0
0.3
0.7
−0.6
−1.2
0.7
0.5
0.6
0.5
0.5
0.4
0.4
0.4
0.4
0.4
Income tax $B
0.1
−0.0
−0.0
−0.1
0.1
0.0
0.1
0.1
−0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
Net income $B
−0.6
−0.9
−0.1
−0.9
0.4
−0.1
0.3
−1.0
−1.6
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.3
0.3
EPS, diluted $
−3.00
−4.48
−0.62
−4.41
1.87
−0.33
1.14
−4.51
−6.76
1.94
1.76
2.24
2.16
2.18
1.70
1.82
1.83
1.87
1.68
Dividend / sh $
0.64
0.64
0.56
0.50
0.43
0.40
0.38
0.35
0.35
0.31
0.29
0.27
0.25
0.22
0.20
0.20
0.20
0.18
0.17
Payout %
−21
−14
−88
−11
22
−121
32
−8
−5
15
16
12
11
10
12
12
11
9
10
ROE %
−36.5
−34.8
−3.7
−21.6
8.3
−1.5
5.0
−17.2
−21.0
8.2
10.8
13.3
13.2
15.5
13.3
13.3
16.0
17.9
·
Shares out B
0.20
0.20
0.21
0.22
0.22
0.22
0.22
0.22
0.23
0.23
0.14
0.14
0.14
0.14
0.14
0.14
0.15
0.15
0.15
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
74 of 74
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed